Medication-Assisted Treatment Guide

No. MAT uses FDA-approved medications that are medically safe and help restore brain chemistry. Unlike illicit opioid use, these medications are prescribed in controlled doses, block the euphoric effects of other opioids, reduce cravings, and are part of a comprehensive treatment plan. Research shows MAT significantly reduces overdose death rates and increases long-term recovery success.

There's no fixed duration. Some people stay on MAT for months, others for years, and some indefinitely. Research suggests that longer durations generally lead to better outcomes. The decision to taper off should be made with your healthcare provider when you're ready, not based on arbitrary timelines. Stopping MAT prematurely significantly increases relapse risk.

Standard employment drug tests typically look for opioids, not specifically for buprenorphine, methadone, or naltrexone. However, some specialized tests can detect these medications. If you're concerned, discuss your MAT with your employer or the testing organization. Legally, employers generally cannot discriminate against people in medication-assisted treatment for legitimate medical conditions.

Yes. Switching between medications is possible and sometimes recommended based on your needs. For example, you might switch from methadone to buprenorphine (with proper medical supervision) or start naltrexone after completing methadone taper. Your healthcare provider can help determine if switching makes sense for your situation.

Most insurance plans, including Medicaid and Medicare, cover MAT medications and treatment. Under the Mental Health Parity and Addiction Equity Act, insurance companies must cover addiction treatment at levels comparable to other medical conditions. Coverage varies by plan, so contact your insurance provider or the treatment facility to verify coverage.

While medications address the physical and neurological aspects of addiction, counseling helps address the behavioral, emotional, and social components. Research shows that MAT combined with behavioral therapy produces the best outcomes. Most MAT programs include some level of counseling, from brief check-ins to intensive therapy, depending on your needs.

MAT is generally considered safer than continuing illicit opioid use during pregnancy. Buprenorphine is often preferred during pregnancy because it has less risk of neonatal abstinence syndrome compared to methadone. If you're pregnant or planning to become pregnant, discuss your MAT options with your healthcare provider—stopping MAT during pregnancy can be dangerous for both you and the baby.

Not every medication works for every person. If one MAT medication isn't effective or causes side effects you can't tolerate, you may benefit from trying another. MAT isn't one-size-fits-all, and finding the right fit may take some adjustment. Work closely with your healthcare provider to find the approach that works best for you.